home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

6.340 -0.010 (-0.16%)

Official Closing Price Updated: 7:00 PM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

3 Undervalued Healthcare Stocks In 2023 ↗

August 31, 2023

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

Via Talk Markets

A Look Into Healthcare Sector Value Stocks ↗

August 14, 2023

Via Benzinga

Organon Reports Results for the Second Quarter Ended June 30, 2023

August 08, 2023

From Organon & Co.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

August 07, 2023

Via Benzinga

Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar

August 01, 2023

From Samsung Bioepis

Via GlobeNewswire

Organon's Return On Capital Employed Insights ↗

May 15, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 15, 2023

Via Benzinga

Organon's Earnings: A Preview ↗

May 03, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

July 31, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks. ↗

July 21, 2023

These stocks can significantly bolster your income.

Via The Motley Fool

Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades' ↗

July 17, 2023

On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV)

Via Benzinga

Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023

July 17, 2023

From Organon & Co.

Via Business Wire

REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 05, 2023

From Organon

Via Business Wire

3 S&P 500 Stocks to Own for the Next 50 Years ↗

July 04, 2023

These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries.

Via InvestorPlace

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 01, 2023

From Organon & Co.

Via Business Wire

Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks ↗

June 29, 2023

These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.

Via The Motley Fool

Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

June 27, 2023

From Organon & Co.

Via Business Wire

Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts ↗

June 26, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields ↗

June 08, 2023

Via Benzinga

Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health

June 07, 2023

From Organon & Co.

Via Business Wire

7 Stocks That Are Long Overdue for a Relief Rally ↗

May 18, 2023

Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment.

Via InvestorPlace

Daily Stock Analysis: Organon & Co ↗

May 15, 2023

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions.

Via Talk Markets

Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts ↗

May 09, 2023

Via Benzinga

Organon Reports Results for the First Quarter Ended March 31, 2023

May 04, 2023

From Organon & Co.

Via Business Wire

Organon To Report First Quarter and Host Conference Call on May 4, 2023

April 20, 2023

From Organon & Co.

Via Business Wire

7 Growth Stocks That Are Trading at a Bargain Price ↗

April 02, 2023

Some analysts suggest that equities are in the beginning of a bull market. If so, now is a good time to look at buying bargain growth stocks.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

March 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com